Metrics raised 1
- Marketing spend to be rebalanced upward (from deliberately tight spending in Q1 to protect cost base)
Vasa Denticity Ltd - Q1 FY27 Earnings Call Summary
Wednesday, August 12, 2026, 12:30 PM IST
Event Participants
Executives
4
Vikas Agarwal (Chairman & Managing Director), Mayank Bawari (VP, Product Supply), Sandeep Agarwal (Whole-Time Director & CFO), Shahid Shams (VP, Marketing)
Analysts
10
Amit, Ankur Gulati, Deepak Poddar, Himanshi, Ketkee, Manish, Mithun G, Nachiket, Siddharth, Swaraj Mehta
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Stockout % | 12.87% | Down from 33% peak and ~15% last year; target below 5% by December; driven by own-brand supply rebuilding, forecast improvements |
| Average Order Value (AOV) | +27% YoY | Boosted by higher-ticket digital dentistry equipment sales (intraoral scanners, 3D printers, milling machines) |
| Order Volume | +8% YoY | Slower than AOV growth; management focused on increasing order frequency per customer |
| Gross Margin | Improved QoQ | First improvement in three quarters; guided 27–30% range, not intending to exceed 33% long-term to maintain fair pricing |
| Own Brand Revenue Mix | ~50% | Own brands roughly half of revenue; strategic focus on in-house portfolio for quality, price, and supply control |
| Digital Dentistry Revenue Mix | <10% | New division (launched Sep 2025) gaining traction; low single-digit adoption vs ~40% globally; drives future consumable attach |
| Cost to Serve per Order | <₹1,000 | Down substantially due to warehouse optimization (7→5 warehouses) and automation; expected to decline further with volume |
| Inventory Addition | +₹16 crores | Increase driven by new brand minimum order quantities (MOQs), COD buffer stock, and InstaDent fast-delivery stocking |
| Delivery Time (National Avg) | <4 days | Tier 1/2 at ~2.5 days; long-tail tier 3/4 and monsoon disruptions raise average |
| Warehouses | 5 (was 7) | Closed redundant facilities in same logistics zones; focus on optimizing existing footprint before new investments |
| Registered Dental Customers | ~2.8 lakh | Out of ~4 lakh registered dentists + ~1 lakh dental students; ~half of registered base has ordered |
| Tier 2/3 Revenue Mix | >50% | Tier 2/3 cities contribute majority of revenue; tier 1 mix smaller with growth room |
Note: Full P&L figures (revenue, profit, balance sheet) were provided in the exchange presentation and not read out on the call; operational metrics above are as discussed.
Geographic & Segment Commentary
In-House Brands vs Third-Party Distribution: Own brands account for ~50% of revenue. The FY26 stockout crisis (33% peak) was concentrated in own brands due to a mix of people issues, compliance/licensing gaps, and supply chain failures. Forward deployment, S&OP planning, and new vendor coverage are being implemented. Platform neutrality is maintained—third-party/MNC products are always available and searchable, even if lower-margin.
Digital Dentistry Division (Launched Sep 2025): Contribution is under 10% of revenue but growing; clinics buying equipment (intraoral scanners, milling machines, 3D printers, imaging) generate recurring consumables, service, and training demand. High-ticket equipment carries 10–20% margins (lower than consumables), but the strategy is consumable attach over equipment margin. Adoption is low single-digit in India vs ~40% globally—a large runway.
Tier 1 vs Tier 2/3/4: Tier 2/3 cities contribute >50% of revenue (tier 3 is largest). Tier 1 is estimated to be as large as tier 2+3+4 combined—management sees it as underpenetrated with strategies to grow. Tier 1 focus is not at the expense of tier 2/3: InstaDent same-day delivery will be piloted first wherever warehouses already exist (metro cities), then expanded based on data (customer demand forms and order metrics).
Company-Specific & Strategic Commentary
In-House Brand Control Strategy: The strategic rationale for own brands is not margin (margin is the outcome) but control—of quality, pricing, and shelf availability. Capital and management attention are directed at rebuilding the own-brand portfolio. Stockout reduced from 33% to 12.87% through forecasting, vendor re-contracting, and demand planning; target is below 5% by December.
Operational Leverage & Automation: Cost base grew far slower than volumes. Employee costs barely moved; cost to serve per order fell materially with warehouse rationalization (7→5). The goal is to automate repetitive work so that when volumes double, routine workload does not. Key projects: AI chatbot (already handling ~60% of queries), voice bot in development, image/photo-search (live), handwriting-to-cart, session-to-order time reduction, personalized dashboards, and self-service refunds with automated reverse pickup and WhatsApp notifications.
InstaDent (Same-Day Delivery): Launched with 3,000–5,000 SKUs available for same-day/next-day delivery in tier 1 PIN codes; target is to optimize to ~1,200 most-important clinical items. Expansion to tier 2/3 planned after data validation. Faster delivery is a core lever to convert the remaining 97% of the dental supply market that is still offline.
Marketing Spend & Funnel: Marketing spend was deliberately held tight this quarter to protect the cost base—this impacted top-of-funnel acquisition. Management acknowledged the trade-off and is working on balancing "spending enough to bring new dentists in without giving back what we've recovered." ATL spend is focused on YouTube and digital education for advanced tech products.
Leadership & People: Two new VPs hired in the last quarter—Shahid Shams (VP Marketing) and Mayank Bawari (VP Supply Chain), both ~15 years' experience. Senior hiring is underway across departments (HR priority). No professional CEO is planned at this stage.
No Acquisitions in FY27: The IDS acquisition was mutually terminated. Management is focused on core operations first; inorganic growth will be considered only where organic growth proves difficult (e.g., specific categories), but there is no plan as of now.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Stockout % | Below 5% (by December 2026) | Internal target; management noted unforeseen events (cyclones, vendor stoppages) could delay; progress "as near zero as possible" |
| Revenue Growth | Sustain Q1 FY27 YoY rate in Q2 | Management expects similar year-on-year growth in Q2; AOV growth expected to moderate as order frequency and customer count catch up |
| Gross Margin | 27–30% (medium-term guidance) | Not intended to exceed 33% long-term — surplus margins will be passed back to customers via pricing |
| Long-Term Revenue | ₹800–1,200 crores (5-year horizon) | Aspirational target stated ~18 months ago; achievable "if we take the right steps" with data/metrics; not a formal guidance but reaffirmed as directionally valid |
| Digital Dentistry Mix | To grow from <10% | Equipment drives consumables attach; mix will shift toward digital over next 2–3 years, though consumables remain the focus |
| Marketing Spend | To be rebalanced upward | Management acknowledged top-of-funnel impact of tight spend and will recalibrate without giving back margin recovery |
| Inventory Days | Optimization ongoing | Inventory up ₹16 crores due to new brand MOQs, COD buffer, InstaDent stocking; guidance in presentation on expected inventory days range |
Risks & Constraints
| Risk | Context |
|---|---|
| Recurrence of Stockouts | Own-brand stockouts peaked at 33% in FY26; now at 12.87%. Management has instituted demand forecasting, S&OP, and forward deployment but conceded that unforeseen events (e.g., cyclone in China, vendor stoppages) can still cause shortfalls. Target is <5% by December; execution risk remains. |
| Marketing Spend Trade-off | Tight marketing in Q1 reduced top-of-funnel acquisition. If the company underspends again, new customer additions and order volume growth could stagnate; if it overspends, the margin recovery could reverse. Management admits it hasn't "perfected" the balance yet. |
| Delivery Time in Tier 2/3 | Expansion into tier 2/3 outpaced route optimization; national average is below 4 days but monsoon/floods inflate it. InstaDent is only in tier 1 currently. If delivery timelines don't improve in non-tiers, wallet-share growth (the core strategy—97% of market still offline) could be limited. |
| Customer Trust & Warranty Gaps | Analyst feedback (via dentist interviews) indicates fear of warranty claims, returns, and on-site service as a key barrier to buying online—especially for high-value equipment. Management acknowledged edge cases in warranty/refund handling and is automating processes, but trust-building is a slower, structural challenge. |
| Competitive Pressure from Offline Distributors | Offline distributors offer demonstration, try-before-buy, and on-site service that DentalKart doesn't provide (except for equipment sold offline via Walden division). International brands entering India could also choose to work with local distributors or other channels, though current tie-ups (e.g., with a French brand, Secrodont) have grown 2.5x. |
| Leadership Churn / Governance Perception | Recent exits (company secretary, independent director) raised investor concerns about governance. Management explained the departures as individual career/policy decisions, but perception risk and the absence of a professional CEO remain watch items. |
Q&A Highlights
Director Departures & Transparency Concerns
- Question: Why are directors and the company secretary leaving? (Siddharth)
- Answer: Independent director left to join another company due to new company policy post-retirement; company secretary left for a better opportunity. On the removed Q&A from last call transcript: "I have no idea about it… I will look into it and get back to you." (Vikas Agarwal)
Stockout Improvement & Timeline
- Question: What is the current stockout % and when will it normalize? (Deepak Poddar)
- Answer: Peak was 33%, now at 12.87% (Q1). Internal target is below 5% by December, but unforeseen events (cyclones in China, vendor stoppages) could delay. Management is "trying to progress near zero." (Vikas Agarwal)
Growth Composition (AOV vs Volume)
- Question: Growth was driven by ~27% AOV rise (high-ticket digital dentistry) while order volume grew only ~8%—how should we model growth? (Deepak Poddar)
- Answer: Management is positive on sustaining Q1 YoY growth in Q2. Digital dentistry is <10% of revenue; margins on high-ticket equipment are lower (10–20%) than consumables. Consumables will remain the focus. The strategy is to drive consumable attach through equipment sales. (Vikas Agarwal)
Margin Drivers & Opex per Order
- Question: What drives margin improvement beyond gross margin, and will opex per order plateau or decline? (Swaraj Mehta)
- Answer: Cost to serve is already down (warehouse optimization, picker productivity—reducing order picking time from ~3 min for 4-SKU orders to 2 min). As volumes grow, percentage will continue to decline. Gross margin guidance is 27–30%, and the company does not intend to exceed 33% to keep pricing fair. (Mayank Bawari, Vikas Agarwal)
Internal KPIs & Data Tracking
- Question: Which metrics should investors track? (Swaraj Mehta)
- Answer: Key internal metrics: OTIF (on-time-in-full deliveries), cost to serve per order (including overhead), AOV, and ARPU. Management also flagged that earlier PPT order volumes were corrected due to an "internal error"—latest figures are accurate. (Vikas Agarwal, Mayank Bawari, Sandeep Agarwal)
Revenue Guidance & Acquisitions
- Question: Is the ₹500–600 crore FY27 and ₹800–1,200 crore FY28 guidance still valid? Are more acquisitions planned? (Mithun G)
- Answer: The ₹800–1,200 crore figure was stated 18 months ago as a 5-year aspirational goal, and it remains "definitely achievable" with the right steps. No acquisitions planned; focus is on core operations first. 100% of sales are domestic; exports not prioritized due to compliance complexity and domestic opportunity. (Vikas Agarwal, Mithun G)
Tier Mix & Customer Base
- Question: What is the revenue split by tier, and how many dentists do you reach? (Himanshi)
- Answer: Tier 2/3 contributes >50% of revenue (tier 3 is largest); tier 1 is smaller but has large growth room. Registered base is ~2.8 lakh dental professionals out of ~4 lakh registered dentists + ~1 lakh students + other professionals (5.5 lakh total). AOV is ~₹4,000–4,500; consumables spend per tier-2 dentist is ~₹10,000/month. Cost to serve is <₹1,000 per order. (Vikas Agarwal, Himanshi)
Dentist Trust — Warranty, Returns & On-Site Service
- Question: Dentists fear warranty claims and returns; offline distributors offer try-before-buy and on-site support. How do you address this? (Amit, Ketkee)
- Answer: 80–90% of warranty/refund claims are resolved within SLA; the problem is edge cases. Automation (AI chatbot, voice bot, self-service refunds with automated reverse pickup and WhatsApp notifications) is being deployed to handle SOPs more consistently. High-value equipment (dental chairs, autoclaves) is also sold through the offline Walden division with installation, training, and AMC/CMC services. Remote installation support is available for cameras, X-ray machines, etc. (Vikas Agarwal, Sandeep Agarwal, Shahid Shams)
Own Brand Mix & Customer Growth Strategy
- Question: What is the revenue split between own brands and distribution, and how will you grow customers/orders? (Ankur Gulati)
- Answer: ~50% own brand, ~50% third-party/distribution. The priority is not new customer acquisition but wallet share per existing customer. Members vs non-members: members have slightly lower AOV but double ARPU. Tech features (slider discounts for higher AOV, recommendations, dashboards) aim to increase order frequency and wallet share. (Vikas Agarwal)
Cash Usage After IDS Acquisition Termination
- Question: With no acquisition, how will the cash be used? (Swaraj Mehta)
- Answer: Cash will be used as working capital in the company going forward. (Vikas Agarwal)
International Brands & Platform Neutrality
- Question: How do international brands view DentalKart given your own brands compete with them? (Nachiket)
- Answer: Platform neutrality is maintained—no forced brand switching; all third-party products remain searchable and available. Example: a French brand (Secrodont) grew from 100 to 250 units post-tie-up, with products reaching tier 1 towns that had no distribution. The company is also building an ads monetization feature for brands. (Vikas Agarwal)
Tier 1 vs Tier 2/3 Focus Strategy
- Question: Why not dominate tier 2/3 first where your right-to-win is stronger, rather than allocating effort to tier 1 where offline competition is tough? (Manish)
- Answer: Current tier 1 focus is only about utilizing existing warehouse investments before new capital deployment. InstaDent will be piloted in warehoused cities first (2–3 quarters of data) before expanding to tier 2/3 dark stores. Tier 2/3 is considered the "right to win"—expansion there is planned after validation. (Vikas Agarwal)
Senior Team Additions & Hiring Plans
- Question: Any senior team additions or plans to strengthen leadership? (Manish)
- Answer: Shahid Shams (VP Marketing) and Mayank Bawari (VP Supply Chain) joined last quarter, both with ~15 years' experience. Further VP hires are planned across departments, with HR as priority. No professional CEO is planned at this stage. Hiring should be completed within the year. (Vikas Agarwal)
Long-Term Gross Margin Levers
- Question: Beyond the 27–30% range, what levers exist for gross margin 5 years out? (Manish)
- Answer: Management does not intend to exceed 33% on product margins—excess will be passed to customers. Additional revenue/margin streams include: platform ad monetization (Colgate/Oral-B type brands), demo services (sending samples to clinics), free sample inclusion in boxes at a cost, and education (charging higher fees for international speakers on webinars). These non-product engines could push combined margins above 33%. (Vikas Agarwal)
Key Takeaway
Vasa Denticity's Q1 FY27 marked the first visible payoff from the FY26 repair effort: gross margins improved for the first time in three quarters, stockouts fell from a 33% peak to 12.87%, and the cost base contracted (5 warehouses vs 7, cost to serve below ₹1,000 per order) even as volumes grew. Growth was disproportionately AOV-led (+27% YoY) from the newly scaled digital dentistry division (<10% of revenue, consumables attach strategy), while order volume grew only 8%—management's near-term focus is converting wallet share and order frequency rather than raw customer acquisition. The company reaffirmed a 27–30% gross margin guidance, a <5% stockout target by December, and a 5-year aspirational revenue goal of ₹800–1,200 crores, while deliberately avoiding acquisitions and maintaining platform neutrality (~50% own-brand mix). Risk watch items include the marketing spend balance (tight Q1 affected the funnel), delivery times in tier 2/3, and the persistence of warranty/return edge cases that dent dentist trust. With new VPs in marketing and supply chain, AI chatbot handling ~60% of queries, and InstaDent same-day delivery piloting in warehouse cities, management expects to sustain Q1 growth into Q2 before scaling the fast-delivery model deeper into tier 2/3 India.
Transcript incomplete — full financial statement figures (revenue, PAT, cash) were provided in the exchange presentation and not read out on the call; summary covers operational and strategic commentary from the transcript.